Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)
Launched by THE LEEDS TEACHING HOSPITALS NHS TRUST · Jan 28, 2014
Trial Information
Current as of June 19, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients referred for lower gastrointestinal endoscopy procedure will be recruited.
- • Any age (1885 years), gender or ethnic background
- • Able and willing to give an informed consent
- Exclusion Criteria:
- • Patients known to be intolerant to endoscopy.
- • Patients with severe lifethreatening comorbidity as judged by the investigator.
- • Patients on therapy with anticoagulation that may preclude taking any biopsies
- • Pregnant women or breast feeding mothers
- • Patient with toxic megacolon
- • patients on medications known to cause bowel inflammation.
About The Leeds Teaching Hospitals Nhs Trust
The Leeds Teaching Hospitals NHS Trust is a prominent healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and advanced medical education. As a leading clinical trial sponsor, the Trust plays a pivotal role in facilitating cutting-edge research initiatives that aim to improve health outcomes and advance medical knowledge. With a multidisciplinary team of experts and access to state-of-the-art facilities, the Trust is dedicated to fostering collaboration and ensuring the highest ethical standards in clinical research, ultimately contributing to the development of new treatments and therapies for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, West Yorkshire, United Kingdom
Leeds, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials